Global & Public Health
Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color
22 Oct, 2020 | 09:41h | UTC
Commentary on Twitter
A new @CDCMMWR estimates since January 2020, 299,000 more people have died than the typical number during the same weeks in previous years. At least 2 out of 3 excess deaths were attributed to #COVID19. Learn more: https://t.co/fg4W6u4e3C. pic.twitter.com/i9TDxrBrTV
— CDC (@CDCgov) October 20, 2020
Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us
22 Oct, 2020 | 09:40h | UTCWill covid-19 vaccines save lives? Current trials aren’t designed to tell us – The BMJ
Commentaries: COVID-19 vaccine trials won’t tell us if the shots save lives, expert notes – CNN AND Coronavirus vaccine trials won’t tell us if they save lives, prevent serious illness or stop transmission – here’s why – The Conversation
Commentary on Twitter
The world is waiting on a vaccine for covid-19 that will reduce the likelihood of getting severely ill and prevent infection. Yet the current phase III trials are not actually set up to prove either, finds Peter Doshi https://t.co/BSb9WiUQXo
— The BMJ (@bmj_latest) October 21, 2020
New calculator predicts risk of hospital admission and mortality from coronavirus 19 in adults
22 Oct, 2020 | 09:37h | UTCSee calculator: QCovid® risk calculator
Commentary on Twitter
A new "living" high quality prediction model for #COVID19 risk for hospitalization and mortality: top 20% risk accounted for 94% of deaths; https://t.co/aPXRM2pHCq calculatorhttps://t.co/gdd8b3j33K @bmj_latest
by @AshClift @JuliaHCox @OxPrimaryCare and colleagues pic.twitter.com/s8TrWWECb0— Eric Topol (@EricTopol) October 21, 2020
Video consultations in primary and specialist care during the covid-19 pandemic and beyond
21 Oct, 2020 | 09:30h | UTCVideo consultations in primary and specialist care during the covid-19 pandemic and beyond – The BMJ
Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials
21 Oct, 2020 | 09:25h | UTCDozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials – Nature
Commentaries: U.K. Preparing COVID-19 Vaccine Trials That Deliberately Expose Study Subjects – NPR AND UK plan to be first to run human challenge Covid trials – BBC
Studies point to big drop in COVID-19 death rates
21 Oct, 2020 | 09:23h | UTCStudies Point To Big Drop In COVID-19 Death Rates – NPR
Viewpoint – COVID-19, children and non-communicable diseases: Translating evidence into action
21 Oct, 2020 | 09:19h | UTC
Commentary on Twitter
"The recognition that NCDs are a massive contributor to COVID-19 mortality and severe illness across all age groups should be a wake-up call to accelerate preventive strategies for NCDs."
New piece on how children & youth are affected by #COVID19 & #NCDshttps://t.co/oXV6UAdgGL pic.twitter.com/WNTZtVAztZ
— Marie Hauerslev (@HauerslevMarie) October 17, 2020
Perspective: COVID-19 in children and young people
21 Oct, 2020 | 09:17h | UTCCOVID-19 in children and young people – Science
Guidelines for care of adults with Down Syndrome
21 Oct, 2020 | 09:14h | UTCMedical Care of Adults With Down Syndrome: A Clinical Guideline – JAMA (free for a limited period)
Editorial: Guidelines for Care of Adults With Down Syndrome
Clinical Report: Evaluation and management of the infant exposed to HIV in the US
21 Oct, 2020 | 09:09h | UTCEvaluation and Management of the Infant Exposed to HIV in the United States – Pediatrics
Commentaries: Pediatrics Group Updates Guidelines on Managing HIV-Exposed Infants – NEJM Journal Watch AND Perinatal Exposure to HIV Requires Specialized, Coordinated Care – AJMC
WHO takes a position on genetically modified mosquitoes
21 Oct, 2020 | 09:02h | UTCWHO takes a position on genetically modified mosquitoes – World Health Organization
Position Statement: Evaluation of genetically modified mosquitoes for the control of vector-borne diseases – World Health Organization
Covid-19: The global crisis — in data
20 Oct, 2020 | 01:45h | UTCCovid-19: The global crisis — in data – Financial Times
Herd immunity and implications for SARS-CoV-2 control
20 Oct, 2020 | 01:44h | UTCHerd Immunity and Implications for SARS-CoV-2 Control – JAMA
Author Interview: Can We Count on Herd Immunity to Control COVID-19? – JAMA
Patient Page: What Is Herd Immunity? – JAMA
Commentary on Twitter
Herd immunity is real. It may be inevitable given our poor handling of COVID-19 and nature of the virus.
But to *deliberately* shoot for natural herd immunity (ie, without a vaccine) makes no sense.
Via @SaadOmer3 @InciYildirim11 @thehowie @JAMA_current https://t.co/PwWc1wMMzE pic.twitter.com/Ybn7vHFnt8
— Nicholas A. Christakis (@NAChristakis) October 19, 2020
Editorial: Covid-19’s known unknowns
20 Oct, 2020 | 01:42h | UTCCovid-19’s known unknowns – The BMJ
Commentary on Twitter
If you are going to read anything today let it be this short editorial @bmj_latest https://t.co/ggvEglehJm pic.twitter.com/hyw21BcZBU
— Maarten van Smeden (@MaartenvSmeden) October 19, 2020
Opinion: The scientific and ethical feasibility of immunity passports
20 Oct, 2020 | 01:41h | UTCThe scientific and ethical feasibility of immunity passports – The Lancet Infectious Diseases
Related: Digital ‘health passport’ trials under way to aid reopening of borders – The Guardian
Covid-19 vaccine protocols reveal that trials are designed to succeed
20 Oct, 2020 | 01:40h | UTCCovid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed – Forbes
Perspective: All eyes on a hurdle race for a SARS-CoV-2 vaccine
20 Oct, 2020 | 01:39h | UTCAll eyes on a hurdle race for a SARS-CoV-2 vaccine – Nature
The household secondary attack rate of SARS-CoV-2: A rapid review
20 Oct, 2020 | 01:36h | UTCThe household secondary attack rate of SARS-CoV-2: A rapid review – Clinical Infectious Diseases
Commentary on Twitter
Household secondary attack rate (SAR) of #SARSCoV2 A rapid review https://t.co/u2YGZYB9Zt The overall pooled random-effects estimate of the household SAR was 17.1% (95% CI: 13.7-21.2%). Household SAR higher among older adult contacts and among contacts of symptomatic cases.
— Carlos del Rio (@CarlosdelRio7) October 16, 2020
Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies
20 Oct, 2020 | 01:30h | UTCCommentary: Desideratum: a developmentalist view of Zika virus infection – The Lancet Infectious Diseases
Meta-analysis: Evidence-based prevention of Alzheimer’s disease
20 Oct, 2020 | 01:21h | UTCCommentaries: Biggest risk factors identified to try and prevent Alzheimer’s disease – BMJ AND Systematic review finds ten lifestyle factors that clearly impact the probability of developing Alzheimer’s disease (AD) – Sharp Brains
Commentary on Twitter
Evidence-based #prevention of #Alzheimers disease https://t.co/XOMiEoMlmI via @JNNP_BMJ #dementia @perryd43 @PennilessScribe @u3Y4BDE @SanWren @lfkraus @the_scholar1 @ktanimara @drsharwood @TargetLatino @LilithResists @Joseph_Santoro @liftdupbyangels @mrtom101 @SteveDitchfield pic.twitter.com/T5hqbzmIwi
— Ian Kremer (@LEAD_Coalition) July 24, 2020
The Lancet: Latest global disease estimates reveal perfect storm of rising chronic diseases and public health failures fuelling COVID-19 pandemic
18 Oct, 2020 | 23:21h | UTCCommentaries: Global rise in chronic diseases combined with Covid-19 bodes ill for world health – CNN AND Global study shows deadly convergence of chronic disease, COVID-19 – CIDRAP
See report: NEW Special issue of The Global Burden of Disease Study 2019
Related Editorial: Global health: time for radical change? – The Lancet
WHO: Herd immunity, lockdowns and COVID-19
18 Oct, 2020 | 23:19h | UTCCoronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19 – World Health Organization
Commentary on Twitter
Herd immunity is a concept used for vaccination, in which a population can be protected from a virus if a threshold of vaccination is reached. Vaccinated people are protected from getting the disease & passing it on, breaking any chains of transmission.
👉https://t.co/X9N7zcyfOX pic.twitter.com/V22iA6OqOq
— World Health Organization (WHO) (@WHO) October 16, 2020
[Preprint] Multi-organ impairment in low-risk individuals with long COVID
18 Oct, 2020 | 23:18h | UTCMulti-organ impairment in low-risk individuals with long COVID – medRxiv
Related study (preprint): Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality criteria for services – medRxiv
Commentary on Twitter
"In a young, low-risk population with ongoing symptoms, almost 70% of individuals have impairment in 1 or more organs 4 months after initial symptoms of #SARSCoV2 infection" #LongCovid https://t.co/gPnDtacI1J by @amibanerjee1 and colleagues
via @ahandvanish<-🙏 pic.twitter.com/7mKEsQgq5l— Eric Topol (@EricTopol) October 17, 2020
NIHR dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid)
18 Oct, 2020 | 23:14h | UTCA dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid) – National Institute for Health Research
News Release: Living with COVID: NIHR publishes dynamic themed review into ‘ongoing COVID’
Commentaries: Coronavirus: ‘Long Covid could be four different syndromes’ – BBC AND Long covid could be four different syndromes, review suggests – The BMJ AND ‘Long COVID’ may affect multiple parts of body and mind, doctors say – Reuters
Answering key questions about COVID-19 vaccines
18 Oct, 2020 | 23:10h | UTCAnswering Key Questions About COVID-19 Vaccines – JAMA
Commentary on Twitter
Many individuals are hesitant about receiving #COVID19 vaccines. It is critical that clinicians stay well informed about emerging data so that they can help patients make sound decisions https://t.co/1QDwOKuDqc @JesseGoodmanMD @ImmunizeOrg @pharmacists
— JAMA (@JAMA_current) October 16, 2020